Published in World J Surg on February 01, 1984
Liver transplantation before 1 year of age. J Pediatr (1987) 3.15
Prognosis of extrahepatic biliary atresia. Arch Dis Child (1989) 1.12
Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology (2001) 6.19
"Occult" hepatitis B virus as source of infection in liver transplant recipients. Lancet (1994) 3.33
Report of a National Conference on Donation after cardiac death. Am J Transplant (2006) 3.04
HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant (2007) 2.50
Pancreatico-duodenal allotransplantation: experimental and clinical experience. Ann Surg (1970) 2.44
Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med (1982) 2.44
The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation (1987) 2.40
Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med (1990) 2.32
Immunologic and nonimmunologic factors: different risks for cadaver and living donor transplantation. Transplantation (2000) 2.25
Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res (1981) 2.25
Orthotopic liver transplantation: a pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection. Hepatology (1985) 2.18
Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology (1992) 2.09
Prolonged cold ischemia time obviates the benefits of 0 HLA mismatches in renal transplantation. Arch Surg (2000) 2.09
Transplantation of discordant xenografts: a review of progress. Immunol Today (1990) 2.00
Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transplant (2007) 2.00
Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients. Radiology (1993) 1.92
Risk factors for chronic rejection in renal allograft recipients. Transplantation (1993) 1.90
Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg (2001) 1.89
Cytomegalovirus-induced immune suppression. I. Humoral immunity. Clin Exp Immunol (1974) 1.86
Association of renal allograft rejection with virus infections. Am J Med (1974) 1.83
Vascular graft thrombosis after pancreatic transplantation: univariate and multivariate operative and nonoperative risk factor analysis. J Am Coll Surg (1996) 1.83
Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology (1995) 1.81
Using transjugular intrahepatic portosystemic shunts to control variceal bleeding before liver transplantation. Ann Intern Med (1992) 1.80
Increased incidence of malignancy during chronic renal failure. Lancet (1975) 1.79
Recurrence of idiopathic nephrotic syndrome after renal transplantation. Lancet (1972) 1.71
Hepatocellular transplantation for metabolic deficiencies: decrease of plasms bilirubin in Gunn rats. Science (1976) 1.65
Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis. Transplantation (1995) 1.65
Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus. N Engl J Med (1988) 1.65
Hepatic resection for secondary neoplasms. Surgery (1982) 1.64
Hepatitis B virus and apparent fulminant non-A, non-B hepatitis. Lancet (1992) 1.63
A randomized trial of exercise and dietary counseling after liver transplantation. Am J Transplant (2006) 1.61
Complications and risks of living donor nephrectomy. Transplantation (1997) 1.61
Liver transplantation in a patient with protoporphyria. Gastroenterology (1989) 1.60
Hepatitis C virus not found in fulminant non-A, non-B hepatitis. Ann Intern Med (1991) 1.58
The impact of an acute rejection episode on long-term renal allograft survival (t1/2). Transplantation (1994) 1.58
Cytomegalovirus-induced immune suppression. II. Cell-mediated immunity. Clin Exp Immunol (1974) 1.55
The potential supply of organ donors. An assessment of the efficacy of organ procurement efforts in the United States. JAMA (1992) 1.54
Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans. N Engl J Med (1990) 1.53
The Epstein-Barr virus in the pathogenesis of posttransplant lymphoproliferative disorders. Clinical, pathologic, and virologic correlation. Surgery (1981) 1.53
Influence of donor age on graft survival after liver transplantation--United Network for Organ Sharing Registry. Liver Transpl Surg (1995) 1.51
Functional analysis of grafts from living donors. Implications for the treatment of older recipients. Ann Surg (1996) 1.51
Colon perforation after renal transplantation: a single-institution review. Clin Transplant (1997) 1.47
Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation. Surgery (1977) 1.45
Fractionated total lymphoid irradiation as preparative immunosuppression in high risk renal transplantation: clinical and immunological studies. Ann Surg (1982) 1.44
Circadian variation in the rejection of rat kidney allografts. Surgery (1973) 1.43
The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors. Transplantation (1995) 1.43
Steroid diabetes in renal transplant recipients: pathogenetic factors and prognosis. Surgery (1973) 1.43
A rapid method for purification of large quantities of anti-lymphocytic serum. Proc Soc Exp Biol Med (1967) 1.42
Systemic fat embolism after renal homotransplantation and treatment with corticosteroids. N Engl J Med (1965) 1.42
Intra-abdominal infections in pancreas transplant recipients. Ann Surg (1986) 1.42
2,500 living donor kidney transplants: a single-center experience. Ann Surg (2001) 1.41
Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure. Hepatology (1992) 1.41
A modified vascular "sleeve" anastomosis for rearterialization in orthotopic liver transplantation in rats. Transplantation (1992) 1.40
The glomerular mesangium. 3. Acute immune mesangial injury: a new model of glomerulonephritis. J Exp Med (1973) 1.40
Hyperglycemic nonketotic coma after liver transplantation. Arch Surg (1972) 1.40
Uremic pericardial effusion. Treatment by catheter drainage and local nonabsorbable steroid administration. Nephron (1976) 1.39
United Network for Organ Sharing center-specific data: our report card. Liver Transpl Surg (1996) 1.39
Reversal of chronic rejection after treatment failure with FK506 and RS61443. Transplantation (1993) 1.38
Infection and rejection of primary hepatic transplant in 93 consecutive patients treated with triple immunosuppressive therapy. Surg Gynecol Obstet (1988) 1.38
Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology (1994) 1.37
Anti-serum to cultured human lymphoblasts: preparation, purification and immunosuppressive properties in man. Ann Surg (1969) 1.37
Autologous islet transplantation to prevent diabetes after pancreatic resection. Ann Surg (1995) 1.37
Cyclosporin A in renal transplantation: a prospective randomized trial. Surgery (1982) 1.36
Cure of dysgerminoma with widespread metastases appearing after renal transplantation. N Engl J Med (1970) 1.36
The effects of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes. N Engl J Med (1989) 1.35
Protection of the donor kidney during homotransplantation. Ann Surg (1966) 1.34
Total or near total pancreatectomy and islet autotransplantation for treatment of chronic pancreatitis. Ann Surg (1980) 1.34
Cytomegalovirus: Clinical virological correlations in renal transplant recipients. Ann Surg (1974) 1.34
Synergistic effects on DNA synthesis of phytohemagglutinin or concanavalin A and lipopolysaccharide in human peripheral blood lymphocytes. J Immunol (1975) 1.32
Liver allograft rejection. An analysis of the use of biopsy in determining outcome of rejection. Am J Surg Pathol (1987) 1.30
Human islet autotransplantation following pancreatectomy. Transplant Proc (1979) 1.30
Prevention of urological complications after kidney transplantation. Ann Surg (1971) 1.29
Pancreatic islet cell transplantation. Surg Clin North Am (1978) 1.28
Renal transplantation in high-risk patients. Arch Surg (1971) 1.28
Seven years' experience with antilymphoblast globulin for renal transplantation from cadaver donors. Ann Surg (1976) 1.26
Renal transplantation in children ages 1 to 5 years. Pediatrics (1978) 1.25
The clinical use of antilymphocyte globulin. N Engl J Med (1971) 1.24
Role of virus infections in immunosuppressed renal transplant patients. Transplant Proc (1973) 1.23
Liver transplantation for severe Amanita phalloides mushroom poisoning. Am J Surg (1990) 1.23
Differences in rejection grading after simultaneous pancreas and kidney transplantation in pigs. Transplantation (1994) 1.22
Mycotic aneurysms in transplant patients. Arch Surg (1976) 1.21
Development of diabetic vascular lesions in normal kidneys transplanted into patients with diabetes mellitus. N Engl J Med (1976) 1.21
Short- and long-term outcomes of kidney transplants with multiple renal arteries. Ann Surg (1995) 1.21
Experimental renal heterotransplantation. I. In widely divergent species. Transplantation (1966) 1.20
One hundred pancreas transplants at a single institution. Ann Surg (1984) 1.20
Effect of initial slow graft function on renal allograft rejection and survival. Clin Transplant (1997) 1.19
Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatology (1996) 1.19
Quantitative glomerular morphology of the normal human kidney. Lab Invest (1983) 1.18
Human islet transplantation: a preliminary report. Transplant Proc (1977) 1.18
Acute fulminant Wegener granulomatosis. Therapy with immunosuppression, hemodialysis, and renal transplantation. Arch Intern Med (1974) 1.18
Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin. Hepatology (1996) 1.17
Morphology of cyclosporine nephrotoxicity and acute rejection in patients immunosuppressed with cyclosporine and prednisone. Surgery (1983) 1.16
A new subcutaneous arteriovenous shunt: applicable in cases where the standard Quinton-Scribner shunt and arteriovenous fistula have failed. Surgery (1973) 1.16
The treatment of chronic uremia in childhood. I. Transplantation. Pediatrics (1970) 1.16
Aspergillosis in 25 renal transplant patients. Epidemiology, clinical presentation, diagnosis, and management. Ann Surg (1983) 1.15
The bleeding cecal ulcer: pathogenesis, angiographic diagnosis, and nonoperative control. Surgery (1972) 1.15
A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients. Ann Surg (1985) 1.15